A-A-51401A
16 September 1986
SUPERSEDING
A-A-0051401(DM)
7 April 1986
COMMERCIAL ITEM DESCRIPTION
NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics:
Shall be Norgestrel and Ethinyl Estradiol Tablets, USP.
Shall be in accordance with the requirements of the USP.
For strength 1, shall contain 0.5 mg Norgestrel and 0.05 mg Ethinyl Estradiol per tablet, within the applicable assay limits.
For strength 2, shall contain 0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol per tablet, within the applicable assay limits.
Workmanship. The tablets shall be free from defects which detract from its appearance or impair their serviceability.
Unit. Package (PG).
For Size 1, shall be supplied 21 tablets (one cycle) in a blister type rectangular package fitted into a plastic platform, imprinted with weekdays as s recording aid to the patient. One package containing 126 tablets (6 filled plastic platforms) together with six plastic case holders, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business